Alternately, homozygous deletion of RNASEH2B has been shown to occur in chronic lymphocytic leukemia (CLL) and other malignancies (274), Similarly, pathogenic mutations in SAMHD1 have been reported in up to 11% of CLL patients (275). This evidence concerns the gene SAMHD1 and B-cell chronic lymphocytic leukemia.